Literature DB >> 10744491

Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis.

T E King.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744491     DOI: 10.1056/NEJM200003303421312

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide.

Authors:  S J Oliver
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 3.  Determinants of initiation and progression of idiopathic pulmonary fibrosis.

Authors:  Robert Matthew Kottmann; Christopher M Hogan; Richard P Phipps; Patricia J Sime
Journal:  Respirology       Date:  2009-09       Impact factor: 6.424

Review 4.  Anti-cytokine therapy in fibrosing alveolitis: where are we now?

Authors:  A Millar
Journal:  Respir Res       Date:  2000-06-20

Review 5.  Pulmonary fibrosis.

Authors:  David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter; Joseph P Lynch
Journal:  Methods Mol Med       Date:  2005

6.  A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features.

Authors:  Bridget A Fernandez; George Fox; Rick Bhatia; Eric Sala; Barbara Noble; Nash Denic; Dzintra Fernandez; Nigel Duguid; Amanda Dohey; Fady Kamel; Laura Edwards; Krista Mahoney; Susan Stuckless; Patrick S Parfrey; Michael O Woods
Journal:  Respir Res       Date:  2012-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.